A Phase 3, Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART 3D Compared ot Microfracture in the Treatment of Articular Cartilage Defects
Latest Information Update: 15 May 2024
At a glance
- Drugs Autologous chondrocyte implantation (Primary)
- Indications Cartilage disorders
- Focus Therapeutic Use
- Sponsors Aesculap Biologics
- 10 May 2024 Planned primary completion date changed from 1 Dec 2024 to 1 Dec 2025.
- 10 May 2024 Status changed from recruiting to active, no longer recruiting.
- 01 Mar 2022 Planned End Date changed from 1 Dec 2021 to 1 Dec 2027.